Popular in Course
verified elite notetaker
Popular in Business
This 6 page Document was uploaded by an elite notetaker on Monday December 21, 2015. The Document belongs to a course at a university taught by a professor in Fall. Since its upload, it has received 9 views.
Reviews for Colby-Pharmaceutical-Company---Product-Pipeline-Review---2014
Report this Material
What is Karma?
Karma is the currency of StudySoup.
You can buy or earn more Karma at anytime and redeem it for class notes, study guides, flashcards, and more!
Date Created: 12/21/15
Colby Pharmaceutical Company – Product Pipeline Review – 2014 Order this report by calling Single User License : US$ 1500 +1 888 391 5441 or Send an email to Corporate User License : US$ 4500 firstname.lastname@example.org with your contact details and questionsif any. © RnRMarketResearch.com ; email@example.com ; Colby Pharmaceutical Company – Product Pipeline Review – 2014 Summary Researcher’s, Colby Pharmaceutical Company – Product Pipeline Review – 2014′, provides an overview of the Colby Pharmaceutical Company’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Company’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Researcher’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. © RnRMarketResearch.com ; firstname.lastname@example.org ; Colby Pharmaceutical Company – Product Pipeline Review – 2014 The report is built using data and information sourced from Researcher’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Researcher’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. © RnRMarketResearch.com ; email@example.com ; Colby Pharmaceutical Company – Product Pipeline Review – 2014 Scope - The report provides brief overview of Colby Pharmaceutical Company including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Colby Pharmaceutical Company’s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects Complete report is available @ http://www.rnrmarketresearch.com/colby- pharmaceutical-company-product-pipeline-review-2014-market-report.html . © RnRMarketResearch.com ; firstname.lastname@example.org ; Colby Pharmaceutical Company – Product Pipeline Review – 2014 Reasons to Buy - Evaluate Colby Pharmaceutical Company’s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Colby Pharmaceutical Company in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Colby Pharmaceutical Company’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Colby Pharmaceutical Company and exploit collaboration and partnership opportunities Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=235065 . © RnRMarketResearch.com ; email@example.com ; Colby Pharmaceutical Company – Product Pipeline Review – 2014 For more details contact Mr. Ritesh Tiwari: firstname.lastname@example.org / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. email@example.com ; +1 888 391 5441
Are you sure you want to buy this material for
You're already Subscribed!
Looks like you've already subscribed to StudySoup, you won't need to purchase another subscription to get this material. To access this material simply click 'View Full Document'